Related Experiment Videos
Monoclonal antibody that defines the prostate specific antigen
F Donn1, T Bruns, L von Meyerinck
1Department of Urology, Marienhospital, Hamburg, Federal Republic of Germany.
The Prostate
|January 1, 1989
Summary
Researchers developed a novel monoclonal antibody targeting a 30-kD protein found in epithelial cells. This antibody was characterized using immunobinding and immunoperoxidase staining techniques for potential diagnostic applications.
Area of Science:
- Immunology
- Biochemistry
- Cell Biology
Background:
- Benign Prostatic Hyperplasia (BPH) involves epithelial cell changes.
- Identifying specific protein markers in BPH is crucial for understanding disease progression.
- Monoclonal antibodies offer high specificity for target antigen detection.
Purpose of the Study:
- To generate and characterize a monoclonal antibody against a specific protein antigen in epithelial fractions of BPH.
- To evaluate the utility of this antibody in immunochemical analyses.
Main Methods:
- Production of monoclonal antibody via hybridoma technology (fusion of Balb/C mouse spleen cells with myeloma cell line P3 x 63 Ag8 6.5.3).
- Immunization of mice with epithelial fractions from BPH tissue.
- Characterization of the antibody using immunobinding assays against various cellular and target antigens.
- Immunoperoxidase staining for antigen localization.
Main Results:
- A monoclonal antibody was successfully generated, recognizing a single protein band at approximately 30-kD.
- The antibody demonstrated specific binding characteristics in immunochemical assays.
- Immunoperoxidase staining confirmed the presence of the target antigen.
Conclusions:
- A novel monoclonal antibody targeting a 30-kD protein associated with BPH has been developed.
- This antibody shows promise as a specific tool for research and potential diagnostic applications in BPH.
- Further studies are warranted to elucidate the precise role of this 30-kD antigen in BPH pathogenesis.